Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine

Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine Publisher Pubmed

Mirzaei R^{1, 2} ; Mohammadzadeh R³ ; Mahdavi F⁴ ; Badrzadeh F⁵ ; Kazemi S⁶ ; Ebrahimi M⁷ ; Soltani F⁸ ; Kazemi S⁶ ; Jeda AS⁹ ; Darvishmotevalli M¹⁰ ; Yousefimashouf R¹ ; Keyvani H⁹ ; Karampoor S⁹

Show Affiliations

1. Department of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
2. Student Research Committee, Hamadan University of Medical Sciences, Hamadan, Iran
3. Department of Microbiology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
4. Department of Medical Parasitology and Mycology, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran
5. Faculty of Medicine, Golestan University of Medical Sciences, Golestan, Iran
6. Studentsâ€™ Seientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
7. Department of Environmental Health, School of Health, Guilan University of Medical Sciences, Rasht, Iran
8. Health Safety and Environment Management Department, Azad University, Ahvaz Branch, Ahvaz, Iran
9. Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
10. Research Center For Health, Safety And Environment (RCHSE), Alborz University of Medical Sciences, Karaj, Iran

Source: International Immunopharmacology Published:2020

Abstract

Coronavirus disease 2019 (COVID-19) is a pandemic infectious disease caused by the novel coronavirus called SARS-CoV-2. There is a gap in our understanding regarding the immunopathogenesis of COVID-19. However, many clinical trials are underway across the world for screening effective drugs against COVID-19. Nevertheless, currently, no proven effective therapies for this virus exists. The vaccines are deemed as a significant part of disease prevention for emerging viral diseases, since, in several cases, other therapeutic choices are limited or non‐existent, or that diseases result in such an accelerated clinical worsening that the efficacy of treatments is restricted. Therefore, effective vaccines against COVID-19 are urgently required to overcome the tremendous burden of mortality and morbidity correlated with SARS-CoV-2. In this review, we will describe the latest evidence regarding outstanding vaccine approaches and the challenges for vaccine production. © 2020 Elsevier B.V.

Related Docs

View other Related Docs

1. Severe Acute Respiratory Syndrome-Coronavirus-2 Spike (S) Protein Based Vaccine Candidates: State of the Art and Future Prospects, Reviews in Medical Virology (2021)

2. A Review of Covid-19 Vaccines and Major Considerations for Diabetic Patients, Biotechnology and Applied Biochemistry (2022)

3. The Chimera of S1 and N Proteins of Sars-Cov-2: Can It Be a Potential Vaccine Candidate for Covid-19?, Expert Review of Vaccines (2022)

4. The Possible Role of Novel Coronavirus 2019 Proteins in the Development of Drugs and Vaccines, Journal of Applied Biotechnology Reports (2020)

5. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)

6. State-Of-The-Art of Nanodiagnostics and Nanotherapeutics Against Sars-Cov-2, ACS Applied Materials and Interfaces (2021)

7. Delving Into Revolutionary Sars-Cov-2 Vaccine Approaches: Molecular and Virological Examinations; Principles of Sars-Cov-2 Vaccine Platform; [Adentrandose En Enfoques Revolucionarios De Vacunas Sars-Cov-2: Examenes Moleculares Y Virologicos; Principios De La Plataforma De Vacunas Sars-Cov-2], Vacunas (2024)

8. Vaccine Design and Delivery Approaches for Covid-19, International Immunopharmacology (2021)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (42)

Seyed Ahmad Seyed Alinaghi (10)

Style	Citing Format
MLA	Mirzaei R, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology, vol. 88, no. , 2020, pp. -.
APA	Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, Kazemi S, Jeda AS, Darvishmotevalli M, Yousefimashouf R, Keyvani H, Karampoor S (2020). Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology, 88(), -.
Chicago	Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology 88, no. (2020): -.
Harvard	Mirzaei R et al. (2020) 'Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine', International Immunopharmacology, 88(), pp. -.
Vancouver	Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, et al.. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology. 2020;88():-.
BibTex	@article{ author = {Mirzaei R and Mohammadzadeh R and Mahdavi F and Badrzadeh F and Kazemi S and Ebrahimi M and Soltani F and Kazemi S and Jeda AS and Darvishmotevalli M and Yousefimashouf R and Keyvani H and Karampoor S}, title = {Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine}, journal = {International Immunopharmacology}, volume = {88}, number = {}, pages = {-}, year = {2020} }
RIS	TY - JOUR AU - Mirzaei R AU - Mohammadzadeh R AU - Mahdavi F AU - Badrzadeh F AU - Kazemi S AU - Ebrahimi M AU - Soltani F AU - Kazemi S AU - Jeda AS AU - Darvishmotevalli M AU - Yousefimashouf R AU - Keyvani H AU - Karampoor S TI - Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine JO - International Immunopharmacology VL - 88 IS - SP - EP - PY - 2020 ER -

Style

Citing Format

MLA

Mirzaei R, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology, vol. 88, no. , 2020, pp. -.

APA

Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, Kazemi S, Jeda AS, Darvishmotevalli M, Yousefimashouf R, Keyvani H, Karampoor S (2020). Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology, 88(), -.

Chicago

Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, Soltani F, et al.. "Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine." International Immunopharmacology 88, no. (2020): -.

Harvard

Mirzaei R et al. (2020) 'Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine', International Immunopharmacology, 88(), pp. -.

Vancouver

Mirzaei R, Mohammadzadeh R, Mahdavi F, Badrzadeh F, Kazemi S, Ebrahimi M, et al.. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine. International Immunopharmacology. 2020;88():-.

BibTex

@article{ author = {Mirzaei R and Mohammadzadeh R and Mahdavi F and Badrzadeh F and Kazemi S and Ebrahimi M and Soltani F and Kazemi S and Jeda AS and Darvishmotevalli M and Yousefimashouf R and Keyvani H and Karampoor S}, title = {Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine}, journal = {International Immunopharmacology}, volume = {88}, number = {}, pages = {-}, year = {2020} }

RIS

TY - JOUR
AU - Mirzaei R
AU - Mohammadzadeh R
AU - Mahdavi F
AU - Badrzadeh F
AU - Kazemi S
AU - Ebrahimi M
AU - Soltani F
AU - Kazemi S
AU - Jeda AS
AU - Darvishmotevalli M
AU - Yousefimashouf R
AU - Keyvani H
AU - Karampoor S
TI - Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine
JO - International Immunopharmacology
VL - 88
IS -
SP -
EP -
PY - 2020
ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract